intravenous-cat LD50 16 mg/kg Polish Journal of Pharmacology and Pharmacy. Vol. 32, Pg. 833, 1980.
intravenous-dog LDLo 19 mg/kg BEHAVIORAL: SOMNOLENCE (GENERAL DEPRESSED ACTIVITY)
BEHAVIORAL: TREMOR
BEHAVIORAL: CONVULSIONS OR EFFECT ON SEIZURE THRESHOLD Drugs under Experimental and Clinical Research. Vol. 10, Pg. 197, 1984.
oral-guinea pig LD50 362 mg/kg Farmaco, Edizione Pratica. Vol. 35, Pg. 49, 1980.
intravenous-guinea pig LDLo 117 mg/kg Farmaco, Edizione Pratica. Vol. 35, Pg. 49, 1980.
oral-human TDLo 9600 mg/kg/8W BEHAVIORAL: SOMNOLENCE (GENERAL DEPRESSED ACTIVITY)
LUNGS, THORAX, OR RESPIRATION: OTHER CHANGES
BEHAVIORAL: TREMOR JAMA, Journal of the American Medical Association. Vol. 238, Pg. 884, 1977.
oral-man TDLo 88 mg/kg/10D-I LIVER: "HEPATITIS (HEPATOCELLULAR NECROSIS), DIFFUSE" Gastroenterology. Vol. 70, Pg. 1136, 1976.
oral-man TDLo 240 mg/kg/2W-I ENDOCRINE: TUMORS
MUSCULOSKELETAL: JOINTS
SENSE ORGANS AND SPECIAL SENSES: CONJUNCTIVE IRRITATION: EYE Journal of Toxicology, Clinical Toxicology. Vol. 20, Pg. 367, 1983.
oral-man TDLo 386 mg/kg/30D- BLOOD: CHANGES IN CELL COUNT (UNSPECIFIED) American Journal of Medicine. Vol. 77, Pg. 345, 1984.
intraperitoneal-mouse LD50 135 mg/kg Journal of Pharmacology and Experimental Therapeutics. Vol. 124, Pg. 53, 1958.
intravenous-mouse LD50 54 mg/kg Archives Internationales de Pharmacodynamie et de Therapie. Vol. 105, Pg. 221, 1956.
oral-mouse LD50 505 mg/kg Farmaco, Edizione Pratica. Vol. 35, Pg. 49, 1980.
intravenous-rabbit LD50 30 mg/kg Polish Journal of Pharmacology and Pharmacy. Vol. 32, Pg. 833, 1980.
intravenous-rat LD50 55 mg/kg Polish Journal of Pharmacology and Pharmacy. Vol. 44, Pg. 187, 1992.
oral-rat LD50 456 mg/kg Arzneimittel-Forschung. Drug Research. Vol. 18, Pg. 1127, 1968.
intraperitoneal-rat LDLo 140 mg/kg Toxicology and Applied Pharmacology. Vol. 1, Pg. 156, 1959.
|